Oncology Journal Issues Research Articles in October 2023 Edition
October 20, 2023
October 20, 2023
CHICAGO, Illinois, Oct. 20 -- JAMA Oncology, an international peer-reviewed journal for scientists, clinicians and trainees in the field of oncology from the American Medical Association, published research articles on the following topics in its October 2023 edition (Vol 9, No. 10):
Original Investigation:
* Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non-Small Cell Lung . . .
Original Investigation:
* Neoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non-Small Cell Lung . . .